회사 소개
- 법인명: Amsal Pharmaceuticals
- 등록 국가: Bosnia and Herzegovina
- 주소: Igmanska 38, Vogošca
- 직원 수: 50 - 99
설명:
A private pharmaceutical company focused on the production and distribution of high-quality, effective and safe generic Rx and OTC drugs and dietary products.
사업 활동
완제 의약품
제조업체공급업체
건강기능식품 & 뉴트라슈티컬
유통업체
생산설비 & 유틸리티 시스템
공급업체
ATC 분류체계 (해부치료화학분류)
공급업체
판매 시장
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, Turkey, Yemen
- Northern Europe: Iceland, Norway, United Kingdom
- Southern Europe: Albania, Andorra, Bosnia and Herzegovina, North Macedonia, Montenegro, Serbia, Vatican City
- Eastern Europe: Belarus, Moldova
주요 제품/서비스
- 완제 의약품: Ferrosal Junior, Norea, Trawelin, OTC medicines, Prescription medicines
- 건강기능식품 & 뉴트라슈티컬: Food Supplements
- 의료기기 & 장비: Medical Devices
- 화장품 및 개인위생용품: Special purpose cosmetics
- 약물전달시스템: Auridol
- 바이오의약품: DenaVIN3
- ATC 분류체계 (해부치료화학분류): Cysturo Junior, Aftalip, Prosturo Neo, Cysturo Neo, Osteorevital Forte, Osteorevital Pro
당사 제품 & 서비스
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
인증
증거
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기